By Michael Smith, North American Correspondent, MedPage Today . Published: April 25, 2013. Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco. AMSTERDAM - An investigational protease inhibitor (PI) led to viral cures in about four out of five hepatitis C virus (HCV) patients, a researcher reported here..